Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05004038
PHASE2

BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:

Sponsor: University of Zurich

View on ClinicalTrials.gov

Summary

A phase IIA randomized double-blind placebo-controlled single-centre study of the effect of Bacillus Calmette-Guérin (BCG) vaccination on the HIV latent reservoir

Official title: A Phase IIA Randomized Double-blind Placebo-controlled Single-centre Study of the Effect of Bacillus Calmette-Guérin (BCG) Vaccination on the HIV Latent Reservoir

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2022-01-04

Completion Date

2023-09-01

Last Updated

2026-05-06

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

BCG Vaccine AJVaccines

Single intradermal injection of BCG Vaccine according to published Summary of Product Characteristics

Locations (1)

University Hospital Zurich

Zurich, Switzerland